Troponin i degradation in serum of patients with acute ischemic stroke

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 1, 2011, Pages 74-80

  Jensen, Jesper K ^a   Hallén, Jonas ^b   Lund, Terje ^c   Madsen, Lene Helleskov ^d   Grieg, Zanina ^b   Januzzi Jr , James L ^e   Atar, Dan ^f,g  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Rigshospitalet   (Denmark)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

Author keywords

Acute ischemic stroke; Degradation; Ischemia; Troponin; Western immunoblotting

Indexed keywords

TROPONIN I;

AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PROTEIN PROCESSING, POST-TRANSLATIONAL; STROKE; TIME FACTORS; TROPONIN I;

EID: 78651371353     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2010.542485     Document Type: Article

References (16)

1. Thygesen K, Alpert JS, White HD. Universal defi nition of myocardial infarction. Eur Heart J 2007;28:2525-38.
2. Ay H, Arsava EM, Saribas O. Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with tro-ponin T levels. Stroke 2002;33:286-9.
3. Jensen JK, Kristensen SR, Bak S, Atar D, Hoilund-Carlsen PF, Mickley H. Frequency and signifi cance of troponin T elevation in acute ischemic stroke. Am J Cardiol 2007;99:108-12.
4. Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999;45:18-20.
5. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modifi cation detected in serum from patients with acute myocardial infarction. Circulation 2000; 102:1221-6.
6. Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Scandinavian Stroke Study Group. Stroke 1985;16:885-90.
7. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classifi cation and natural history of clinically identifi able subtypes of cerebral infarction. Lancet 1991;337:1521-6.
8. Madsen LH, Christensen G, Lund T, Serebruany VL, Granger CB, Hoen I, Grieg Z, Alexander JH, Jaffe AS, Van Eyk JE, Atar D. Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ Res 2006;99:1141-7.
9. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006;48:1-11.
10. Witt BJ, Brown RD, Jr., Jacobsen SJ, Weston SA, Yawn BP, Roger VL. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med 2005;143:785-92.
11. Goldstein DS. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke 1979;10:253-9.
12. Kolin A, Norris J W. Myocardial damage from acute cerebral lesions. Stroke 1984;15:990-3.
13. Zaroff JG, Pawlikowska L, Miss JC, Yarlagadda S, Ha C, Achrol A, Kwork PY, McCullock CE, Lawton MT, Ko N, Smith W, Young WL. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke 2006;37:1680-5.
14. McDonough JL, Labugger R, Pickett W, Tse MY, MacKenzie S, Pang SC, Atar D, Ropchan G, Van Eyk JE. Cardiac tro-ponin I is modified in the myocardium of bypass patients. Circulation 2001;103:58-64.
15. Ammann P, Pfi sterer M, Fehr T, Rickli H. Raised cardiac troponins. BMJ 2004;328:1028-9.
16. Madsen LH, Lund T, Grieg Z, Nygaard S, Holmvang L, Jurlander B, Grande P, Christensen G, Atar D. Cardiac tro-ponin I degradation in serum of patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous septal ablation. Cardiology 2009;114:167-73.